Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
Magellan Health (MGLN) versus UnitedHealth Group (NYSE:UNH) Critical Analysis
Magellan Health (NASDAQ: MGLN) and UnitedHealth Group (NYSE:UNH) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitabiliy, institutional ownership and valuation.
Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
Earnings & Valuation
This table compares Magellan Health and UnitedHealth Group’s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| Magellan Health | $5.03 billion | 0.38 | $245.90 million | $3.46 | 23.08 |
| UnitedHealth Group | $189.04 billion | 0.98 | $14.99 billion | $8.54 | 22.46 |
UnitedHealth Group has higher revenue and earnings than Magellan Health. UnitedHealth Group is trading at a lower price-to-earnings ratio than Magellan Health, indicating that it is currently the more affordable of the two stocks.
Dividends
UnitedHealth Group pays an annual dividend of $3.00 per share and has a dividend yield of 1.6%. Magellan Health does not pay a dividend. UnitedHealth Group pays out 35.1% of its earnings in the form of a dividend. Magellan Health has increased its dividend for 7 consecutive years.
Volatility and Risk
Magellan Health has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, UnitedHealth Group has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Magellan Health and UnitedHealth Group, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Magellan Health | 1 | 0 | 3 | 0 | 2.50 |
| UnitedHealth Group | 0 | 0 | 21 | 0 | 3.00 |
Magellan Health currently has a consensus price target of $80.25, suggesting a potential upside of 0.50%. UnitedHealth Group has a consensus price target of $199.55, suggesting a potential upside of 4.05%. Given UnitedHealth Group’s stronger consensus rating and higher possible upside, analysts plainly believe UnitedHealth Group is more favorable than Magellan Health.
Insider & Institutional Ownership
94.1% of Magellan Health shares are owned by institutional investors. Comparatively, 86.2% of UnitedHealth Group shares are owned by institutional investors. 3.6% of Magellan Health shares are owned by insiders. Comparatively, 0.9% of UnitedHealth Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Magellan Health and UnitedHealth Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Magellan Health | 1.64% | 9.05% | 4.21% |
| UnitedHealth Group | 4.32% | 21.52% | 6.81% |
Summary
UnitedHealth Group beats Magellan Health on 13 of the 17 factors compared between the two stocks.
About Magellan Health
About UnitedHealth Group